Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: The ESCAPE trial, a pragmatic cluster randomized trial in general practice

Trials

Volumn 14, Issue 1, 2013, Pages

  Pouchain, Denis ^a,b   Lièvre, Michel ^c   Huas, Dominique ^a,b   Lebeau, Jean Pierre ^a,b   Renard, Vincent ^a,d   Bruckert, Eric ^e   Girerd, Xavier ^e   Boutitie, Florent ^f  

^a Collège National des Généralistes Enseignants ^*  (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITÉ LYON 1   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Cluster randomized trial; General practice; Hypertension; Primary prevention

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIET; EXERCISE; FRANCE; GENERAL PRACTICE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; LINEAR MODELS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; QUALITY OF LIFE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884764519     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-318     Document Type: Article

References (31)

1. French National Authority for Health Management of Adults with Essential Hypertension 2005, http://www.has-sante.fr/portail/jcms/c_272459/prise-en-charge-des-patients-adultes-atteints-dhypertension-arterielle-essentielle-actualisation-2005-cette-recommandation-est-suspendue, French National Authority for Health.
2. French National Authority for Health Drug Treatment of Type 2 Diabetes 2006, http://www.has-sante.fr/portail/jcms/c_459270/traitement-medicamenteux-du-diabete-de-type-2-recommandation-retiree-le-2-mai-2011, French National Authority for Health.
3. Mancia G, De-Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De-Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 2007(28):1462-1536.
4. Samson S, Ricordeau P, Pepin S, Tilly B, Weill A, Allemand H. Hypertension artérielle et facteurs de risque associés: évolutions des traitements entre 2000 et 2006. Points de repère 2007, 10:1-8. 3725788, 23936684.
5. Mounier-Vehier C, Amah G, Covillard J, Jaboureck O, Phan TM. Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Arch Mal Coeur Vaiss 2002, 95:667-672.
6. Godet-Mardirossian H, Girerd X, Vernay M, Chamontin B, Castetbon K, De-Peretti C. Patterns of hypertension management in France (ENNS 2006 to 2007). Eur J Prev Cardiol 2012, 19:213-220. 10.1177/1741826710394303, 21450611.
7. Wagner A, Arveiler D, Ruidavets JB, Cottel D, Bongard V, Dallongeville J, Ferrières J, Amouyel P, Haas B. Summary statements of hypertension in France in 2007: the Mona Lisa study. BEH 2008, 49/50:483-486.
8. Nicodeme R, Albessard A, Amar J, Chamontin B, Lang T. Poor blood pressure control in general practice: in search of explanations. Arch Cardiovasc Dis 2009, 102:477-483. 10.1016/j.acvd.2009.02.013, 19664567.
9. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B. PRATIK study investigators: hypertension in high-risk patients: beware of the underuse of effective combination therapy: results of the PRATIK study. J Hypertens 2002, 20:779-784. 10.1097/00004872-200204000-00038, 11910316.
10. Wagner A, Sadoun A, Dallongeville J, Ferrières J, Amouyel P, Ruidavets JB, Arveiler D. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 2011, 29:43-50. 10.1097/HJH.0b013e32833f9c4d, 20852444.
11. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 2006, 47:345-351. 10.1161/01.HYP.0000200702.76436.4b, 16432045.
12. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007, 167:141-147. 10.1001/archinte.167.2.141, 17242314.
13. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ 2010, doi:10.1136/bmj.c3995.
14. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010, DOI:10.1002/14651858.CD005182.pub4.
15. Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, Ten-Have TR, Bilker WB. Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial. Pharmacotherapy 2006, 26:1342-1347. 10.1592/phco.26.9.1342, 16945057.
16. Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomized controlled trial. BMJ 2000, 320:686-690. 10.1136/bmj.320.7236.686, 27312, 10710578.
17. New JP, Mason JM, Freemantle N, Teasdale S, Wong L, Bruce NJ, Burns JA, Gibson JM. Educational outreach in diabetes to encourage practice nurses to use primary care hypertension and hyperlipidemia guidelines (EDEN): a randomized controlled trial. Diabet Med 2004, 21:599-603. 10.1111/j.1464-5491.2004.01213.x, 15154946.
18. Ornstein S, Jenkins RG, Nietert PJ, Feifer C, Roylance LF, Nemeth L, Corley S, Dickerson L, Bradford WD, Litvin C. A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. Ann Intern Med 2004, 141:523-532. 10.7326/0003-4819-141-7-200410050-00008, 15466769.
19. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and statistics in medicine. Stat Med 2007, 26:2-19. 10.1002/sim.2731, 17136746.
20. Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med 2001, 30:1044-1048.
21. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991, 83:356-362. 10.1161/01.CIR.83.1.356, 1984895.
22. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999, 28:319-326. 10.1093/ije/28.2.319, 10342698.
23. Roethlisberger FJ, Dickson WJ, Wright A. Management and the Worker: An Account of a Research Program Conducted by the Western Electric Company, Hawthorne Works, Chicago 1939, Chicago: Harvard University Press.
24. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration: age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
25. Baigent C, Blackwell L, Collins R, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 2009, 373:1849-1860. 2715005, 19482214.
26. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R. Prevention of Progression of Arterial Disease and Diabetes Study Group, Diabetes Registry Group, Royal College of Physicians Edinburgh: the prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008, doi:10.1136/bmj.a1840.
27. Lebeau JP, Pouchain D, Huas D, Wilmart F, Dibao-Dina C, Boutitie F. ESCAPE-ancillary blood pressure measurement study: end-digit preference in blood pressure measurement within a cluster-randomized trial. Blood Press Monit 2011, 16:74-79. 10.1097/MBP.0b013e328344d067, 21358538.
28. Nelson MR, Quinn S, Bowers-Ingram L, Nelson JM, Winzenberg TM. Cluster-randomized controlled trial of oscillometric versus manual sphygmomanometer for blood pressure management in primary care (CRAB). Am J Hypertens 2009, 22:598-603. 10.1038/ajh.2009.55, 19300424.
29. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De-Bacquer D, Collier T, De-Backer G, Faergeman O. EUROACTION study group: nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention program (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomized controlled trial. Lancet 2008, 371:1999-2012. 10.1016/S0140-6736(08)60868-5, 18555911.
30. Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J. SPHERE study team: effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomized controlled trial. BMJ 2009, doi:10.1136/bmj.b4220.
31. Pladevall M, Brotons C, Gabriel R, Arnau A, Suarez C, de la-Figuera M, Marquez E, Coca A, Sobrino J, Divine G, Heisler M, Williams LK. Writing committee on behalf of the COM99 study group: multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation 2010, 122:1183-1191. 10.1161/CIRCULATIONAHA.109.892778, 3001186, 20823391.